HOUSTON, May 22, 2017 /PRNewswire/ -- AACN Conference, Booth #3609 -- Halyard Health (NYSE: HYH), a medical technology company focused on eliminating pain, speeding recovery and preventing infection, today announced an expansion of its high performance CORGRIP* Nasogastric/Nasointestinal (NG/NI) Tube Retention System. CORGRIP is now compatible for use with sump tubes up to 18 FR, providing a more secure connection for decompression, suction and drainage of the stomach. The use of this securement device may reduce the overall costs of patient care by reducing multiple procedures from dislodged tubes.

CORGRIP features a side lock clamp designed for quick placement, and torque technology aids magnet connection by articulating the tip of the delivery catheter.

Benefits of the CORGRIP NG/NI Tube Retention System include:

• A reduction in unnecessary X-rays for replacement procedures.
• Higher level of calorie intake for patients.
• Prevention of discomfort and potential trauma related to repeated procedures.
• Cost reductions as a result of improved outcomes related to continuous enteral therapy and fewer procedures.

"At Halyard, we are focused on delivering industry-leading digestive health products that improve patient outcomes," said Jamie Handler, Director of North American Marketing, Core Devices, at Halyard Health. "The CORGRIP device is already a trusted product among Intensive Care Unit clinicians. Extending its use to sump tubes will benefit both hospitals and patients by potentially preventing even more tube dislodgements and reducing the need for nasogastric and nasoenteric feeding tube replacement procedures."  

The CORGRIP NG/NI Tube Retention System including expanded support for sump tubes is available immediately. For more information on Halyard's line of enteral feeding products for digestive health, visit us at www.halyardhealth.com/digestivehealth. 

About Halyard Health

Halyard Health (NYSE: HYH) is a medical technology company focused on eliminating pain, speeding recovery and preventing infection for healthcare providers and their patients. Headquartered in Alpharetta, Georgia, Halyard is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery and preventing healthcare-associated infections. Halyard's business segments - Medical Devices and Surgical and Infection Prevention (S&IP) - develop, manufacture and market clinically superior solutions that improve medical outcomes and business performance in more than 100 countries. For more information, visit www.halyardhealth.com.

*Registered Trademarks or Trademarks of Halyard Health, Inc. or its affiliates.

SOURCE Halyard Health